EMEA-003038-PIP01-21
Key facts
| Active substance |
lutetium (177Lu) chloride
|
| Therapeutic area |
Other
|
| Decision number |
P/0433/2021
|
| PIP number |
EMEA-003038-PIP01-21
|
| Pharmaceutical form(s) |
Radiopharmaceutical precursor
|
| Condition(s) / indication(s) |
Radiolabelling agent
|
| Route(s) of administration |
|
| Contact for public enquiries |
Eckert & Ziegler Radiopharma GmbH
Email: regaffairs.radiopharma@ezag.de |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|